Keyword: University of Pittsburgh School of Medicine
Two discoveries related to a combination treatment and genetic testing could improve the prognosis for patients with pancreatic cancer.
Researchers at the University of Pittsburgh have figured out a way to harness the harmful protein TDP-43 so it can't form toxic clumps in the brain.
More than 20% of liver cancer patients have a gene mutation that could make them particularly responsive to mTOR inhibition, a Pitt team found.
A University of Pittsburgh team is using a viral vector to deliver proteins into the pancreas that transform alpha cells into insulin-producing cells.